Upcoming Events
December 2026
2026 ISPE Pharma 4.0™ and Biopharma Conference ISPE Women in Pharma® Christmas City Walk
Tuesday 8 December 1800 | Separate Registration required, Members Only
Kicking off the 2026 ISPE Pharma 4.0™ and Biopharma Conference, we’re excited to invite you to a relaxed and energizing Tuesday evening Women in Pharma Walk Christmas market visit in beautiful Berlin! Whether you're reconnecting with colleagues or meeting new faces, this is a perfect way to start the week — with movement, conversation, and community. Meeting Point Brandenburg Gate we will gather here before starting our easy walk of approximately 3 km ending at the Christmas Market at Gendarmenmarkt. Any additional costs are the responsibility of the individual. This is available to ISPE Members only. Additional Details to follow for registered attendees. Separate registration required.
2026 ISPE Pharma 4.0™ and Biopharma Conference session: What Inspectors Really Expect from Pharma 4.0™ Systems Powered by ISPE Women In Pharma®
Friday 11 December 1300 – 1330
This session explores how regulatory expectations are evolving as pharmaceutical operations become increasingly digitalized through MES, electronic batch records, cloud-based systems, advanced analytics and AI-supported quality processes.
While Pharma 4.0™ creates major opportunities for efficiency and control, it also introduces new inspection challenges related to data integrity, governance, traceability and the reliability of digital evidence.
Drawing from practical GMP audit and inspection experience, this presentation will examine what generates trust in highly digital environments, common findings related to audit trails, user access, hybrid systems, and AI-assisted decisions, and how companies can strengthen inspection readiness through clear digital governance.
The session will also briefly address the FDA PreCheck Pilot Program as an example of how regulators may increasingly move toward more predictive and data-enabled oversight models. The presentation supports this topic by translating regulatory trends in Pharma 4.0™ into practical GMP expectations and actionable strategies for organizations implementing smart technologies and preparing for inspections